Recent TMO News
- Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study • Business Wire • 01/10/2025 12:15:00 AM
- Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 • Business Wire • 01/03/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:10:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:06:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:03:37 PM
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025 • Business Wire • 01/02/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2024 09:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 09:13:59 PM
- Thermo Fisher Scientific Completes $1B Share Repurchase • Business Wire • 12/04/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/03/2024 10:32:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 10:09:15 PM
- Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases • Business Wire • 11/15/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2024 09:42:25 PM
- Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets • GlobeNewswire Inc. • 11/12/2024 02:00:00 PM
- Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024 • Business Wire • 11/11/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/08/2024 09:53:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2024 09:29:58 PM
- Thermo Fisher Scientific Declares Quarterly Dividend • Business Wire • 11/07/2024 10:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/07/2024 09:54:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/06/2024 10:03:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:30:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:16:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 08:09:30 PM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM